Indeed, the results reported here demonstrate that expression of an anti-inflammatory IL-37 cytokine is able to reduce neuroinflammation and cognitive decline in a mouse model of Alzheimer’s disease. This evidence concerns the gene IL37 and early-onset autosomal dominant Alzheimer disease.